This summary was created by AI, based on 1 opinions in the last 12 months.
Experts have different opinions on Kenvue (KVUE-N) stock. One expert believes that the activist investor is too harsh, considering the pressure on the entire health/beauty sector. The stock has only seen a 6% increase this year, despite being spun off from JNJ. Overall, there seems to be a mixed view on the performance and potential of Kenvue.
Spun off from JNJ, but shares are up only 6% this year. The activist investor is too harsh, because the entire health/beauty sector is under pressure.
Consumer health spinoff from J&J. First rate consumer products business. Trading at discount to peers in sector. ~4% dividend attractive. Excellent array of brands in portfolio. Litigation always a concern, but overall not worried for the long term.
A JNJ spin-off, done with a lot of debt which gives him pause. Their PE is high. Is really concerned is that JNJ also spun off the liability to the talcum powder lawsuits which KVUE now carries.
He owns JNJ. Lots of regard for KVUE, but hasn't initiated a position. Needs a period of seasoning to transition from IPO to reality. He's watching and waiting. Meaningful discount to CHD, but of similar quality.
Consumer products spinoff from Johnson & Johnson.
Would not buy at current share price (19x earnings).
Growth is slow (3-4%).
Sees better opportunities elsewhere.
Assumed product liability on products - very expensive.
Kenvue is a American stock, trading under the symbol KVUE-N on the New York Stock Exchange (KVUE). It is usually referred to as NYSE:KVUE or KVUE-N
In the last year, 1 stock analyst published opinions about KVUE-N. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Kenvue.
Kenvue was recommended as a Top Pick by on . Read the latest stock experts ratings for Kenvue.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
In the last year, there was no coverage of Kenvue published on Stockchase.
On 2024-12-13, Kenvue (KVUE-N) stock closed at a price of $22.21.
An activist investor is inside the company now. Pays a 3.5% dividend. Not followed that much by Wall Street, but offers decent growth.